Navigation Links
Stowers Institute's Baumann Lab identifies key step in maturation pathway of telomerase
Date:12/5/2008

The Stowers Institute's Baumann Lab has discovered an important step in the maturation pathway of telomerase, the enzyme that replenishes the sequences that are lost at chromosome ends with every cell division. The findings were published today in the Advance Online Publication of Nature.

Telomerase is viewed as a promising cancer treatment target because its inhibition selectively kills cancer cells. In order to identify small molecules that block telomerase, it is critical to decipher how the enzyme is made and assembled from its components. Telomerase uses part of an RNA subunit as a template to add telomeric DNA to the ends of chromosomes. The Baumann Lab found that this RNA subunit is first made as a longer inactive form that must be processed into a shorter mature form for telomerase to function.

"We discovered a new pathway of RNA 3' end (tail end) processing," said Jeremy Bunch, Research Technician III and co-equal first author on the paper. "The 3' ends of many RNAs must be processed to produce a mature and functional form. Generally, this involves exonucleolytic degradation, the gradual removal of nucleotides one at a time until the mature end has been reached. Some RNAs are cleaved near the end before exonucleolytic degradation proceeds to generate the mature end. We now show that 3' end processing for telomerase RNA uses a fundamentally different and novel pathway."

"We demonstrate that the machinery that removes introns from messenger RNAs also functions in generating the mature 3' end of the telomerase RNA subunit," said Jessica Box, Research Technician I and co-equal first author on the paper. "It was highly unexpected that the spliceosome could have such a function, as the two steps of removing an internal piece of RNA and gluing the flanking ends together are tightly coupled during intron removal. To our knowledge this is the first example where uncoupling of the first and second step of splicing generates a functional product in a single-step reaction."

The work sheds light on human health by demonstrating that interfering with telomerase maturation can inactivate telomerase. Because finding inhibitors for telomerase has been challenging, the identification of a whole set of potential new targets is welcome news for researchers in the Baumann Lab.

"If we can now identify those factors that are specifically required for telomerase processing, we could have new targets for telomerase inhibition in cancer cells," said Peter Baumann, Ph.D., Assistant Investigator and senior author on the paper. "Defects in the processing machinery for human telomerase are also likely to compromise telomerase function and may thus contribute to diseases such as dyskeratosis congenita, aplastic anemia, and idiopathic pulmonary fibrosis."


'/>"/>

Contact: Marie Jennings
mfj@stowers-institute.org
816-926-4015
Stowers Institute for Medical Research
Source:Eurekalert

Related biology news :

1. Stowers Institutes Linheng Li Lab expands understanding of bone marrow stem cell niche
2. Stowers Institutes Workman Lab discovers novel histone demethylase protein complex
3. Stowers Institutes Shilatifard Lab identifies new role for factor critical to transcription
4. Stowers Institute researchers identify gene linked to vertebral defects in patient populations
5. Stowers Proteomics Center devises method for assigning probabilities to human protein interactions
6. Stowers Institutes Hawley Lab identifies factors responsible for restart of meiotic cycle
7. Stowers Institutes Xie Lab demonstrates dual intrinsic and extrinsic control of stem cell aging
8. New study spotlights National Institutes of Health grant outcomes for clinical research
9. National Institutes of Health award Williams professor $217,710 research grant
10. Baumann lab identifies elusive telomere RNA subunit in single cell model
11. Study identifies genetic variants giving rise to differences in metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: